Preexisting influenza-specific CD4+ T cells correlate with disease protection against influenza challenge in humans

Wilkinson, Tom M, Li, Chris K F, Chui, Cecilia S C, Huang, Arthur K Y, Perkins, Molly, Liebner, Julia C, Lambkin-Williams, Rob, Gilbert, Anthony +7 more·2012·Nature Medicine

Cited by (982)

Items 301–400 of 982

  1. Clinical Advances in Viral-Vectored Influenza Vaccines
    Sarah Sebastian, Teresa Lambe · 2018 · Vaccines
  2. Baculovirus Surface Display of Immunogenic Proteins for Vaccine Development
    Premanand Balraj, Zhong Wee Poh, Mookkan Prabakaran · 2018 · Viruses
  3. Correlates of Protection
    Stanley Alan Plotkin, Peter B. Gilbert · 2017 · Elsevier eBooks
  4. Memory CD4 T cell-derived IL-2 synergizes with viral infection to exacerbate lung inflammation
    Karl Kai McKinstry, Fahmida Alam, Valeria Flores-Malavet, Mate Z. Nagy, Stewart Sell, Andrea May Cooper, Susan L. Swain, Tara M. Strutt · 2019 · PLoS Pathogens
  5. SARS-CoV-2—The Role of Natural Immunity: A Narrative Review
    Sara Diani, Erika A. Leonardi, Attilio Cavezzi, Simona Ferrari, Oriana Iacono, Alice Limoli, Zoe Bouslenko, Daniele Natalini, Stefania Conti, Mauro Mantovani et al. · 2022 · Journal of Clinical Medicine
  6. The Specificity of Targeted Vaccines for APC Surface Molecules Influences the Immune Response Phenotype
    Gunnveig Grødeland, Siri Mjaaland, Gro Tunheim, Agnete Brunsvik Fredriksen, Bjarne Bogen · 2013 · PLoS ONE
  7. Epitope specific T‐cell responses against influenza A in a healthy population
    Miloje Savić, Jennifer Lynn Dembinski, Yohan Kim, Gro Tunheim, Rebecca Jane Cox, Fredrik Oftung, Bjoern Peters, Siri Mjaaland · 2015 · Immunology
  8. Use it or lose it: establishment and persistence of T cell memory
    K. Kedzierska, S. Valkenburg, P. Doherty, M. Davenport, V. Venturi · 2012 · Front. Immun.
  9. Superior antigen-specific CD4+T-cell response with AS03-adjuvantation of a trivalent influenza vaccine in a randomised trial of adults aged 65 and older
    Robert B. Couch, Jose Maria Bayas, Covadonga Caso, Innocent Nnadi Mbawuike, Concepción Núñez López, Carine Claeys, Mohamed El Idrissi, Caroline Hervé, Béatrice Laupèze, Lidia Oostvogels et al. · 2014 · BMC Infectious Diseases
  10. The Role of CD4 T Cell Memory in Generating Protective Immunity to Novel and Potentially Pandemic Strains of Influenza
    Anthony T. DiPiazza, Katherine A. Richards, Zackery A. G. Knowlden, Jennifer Lynn Nayak, Andrea J. Sant · 2016 · Frontiers in Immunology
  11. New Insights into the Generation of CD4 Memory May Shape Future Vaccine Strategies for Influenza
    Priyadharshini Devarajan, Bianca Bautista, Allen M. Vong, Karl Kai McKinstry, Tara M. Strutt, Susan L. Swain · 2016 · Frontiers in Immunology
  12. Circulating Memory CD4+ T Cells Target Conserved Epitopes of Rhinovirus Capsid Proteins and Respond Rapidly to Experimental Infection in Humans
    Lyndsey M. Muehling, Duy T Mai, William W. Kwok, Peter W. Heymann, Anna Pomés, Judith A. Woodfolk · 2016 · The Journal of Immunology
  13. A humanized mouse model identifies key amino acids for low immunogenicity of H7N9 vaccines
    Yamato Wada, Arnone Nithichanon, Eri Nobusawa, Leonard Moise, William D Martin, Norio Yamamoto, Kazutaka Terahara, Haruhisa Hagiwara, Takato Odagiri, Masato Tashiro et al. · 2017 · Scientific Reports
  14. OVX836 a recombinant nucleoprotein vaccine inducing cellular responses and protective efficacy against multiple influenza A subtypes
    Judith Mónica del Campo, Andrés Pizzorno, Sophia Djebali, Julien Bouley, Marjorie Haller, Jimena Pérez‐Vargas, Bruno Lina, Guy Boivin, Marie‐Ève Hamelin, Florence Nicolas et al. · 2019 · npj Vaccines
  15. Induction of Cross-Reactive Hemagglutination Inhibiting Antibody and Polyfunctional CD4+ T-Cell Responses by a Recombinant Matrix-M–Adjuvanted Hemagglutinin Nanoparticle Influenza Vaccine
    Vivek Shinde, Rongman Cai, Joyce S. Plested, Iksung Cho, Jamie Fiske, Xuan Pham, Mingzhu Zhu, Shane Cloney-Clark, Nan Wang, Haixia Zhou et al. · 2020 · Clinical Infectious Diseases
  16. Clonotypic analysis of protective influenza M2e-specific lung resident Th17 memory cells reveals extensive functional diversity
    Ajibola Omokanye, Li Ching Ong, Cristina Lebrero‐Fernández, Valentina Bernasconi, Karin Schön, Anneli Strömberg, Mats Bemark, Xavier Saelens, Paulo Czarnewski, Nils Yngve Lycke · 2022 · Mucosal Immunology
  17. Correlation between Human Leukocyte Antigen Class II Alleles and HAI Titers Detected Post-Influenza Vaccination
    Alastair James Moss, Fiona Gaughran, Aliyye Karasu, Anthony S. Gilbert, Alex Mann, Colin M Gelder, JOHN S. OXFORD, Henry A. F. Stephens, Rob Lambkin‐Williams · 2013 · PLoS ONE
  18. A Human CD4+T Cell Epitope in the Influenza Hemagglutinin Is Cross-Reactive to Influenza A Virus Subtypes and to Influenza B Virus
    Jenny Aurielle B. Babon, John Cruz, Francis A. Ennis, Liusong Yin, Masanori Terajima · 2012 · Journal of Virology
  19. Combined local and systemic immunization is essential for durable T-cell mediated heterosubtypic immunity against influenza A virus
    Ida Elin Maria Uddback, Line Pedersen, Sara Ram Pedersen, Maria Abildgaard Steffensen, Peter Johannes Holst, Allan Randrup Thomsen, Jan Pravsgaard Christensen · 2016 · Scientific Reports
  20. The effective rate of influenza reassortment is limited during human infection
    Ashley Sobel Leonard, Micah T. McClain, Gavin J. D. Smith, David E. Wentworth, Rebecca Halpin, Xudong Lin, Amy Ransier, Timothy B. Stockwell, Suman R. Das, Anthony S. Gilbert et al. · 2017 · PLoS Pathogens
  21. Investigation of CD4 and CD8 T cell-mediated protection against influenza A virus in a cohort study
    Tim K. Tsang, Kwok-Tai Lam, Yinping Liu, Vicky J. Fang, Xiaofeng Mu, Nancy Leung, Malik J. S. Peiris, Gabriel Matthew Leung, Benjamin John Cowling, Wenwei Tu · 2022 · BMC Medicine
  22. Nucleocapsid-specific T cell responses associate with control of SARS-CoV-2 in the upper airways before seroconversion
    Tabea M. Eser, Olga Baranov, Manuel Huth, Mohammed I. M. Ahmed, Flora Deák, Kathrin Held, Luming Lin, Kami Pekayvaz, Alexander Leunig, Leo Nicolai et al. · 2023 · Nature Communications
  23. An intranasal combination vaccine induces systemic and mucosal immunity against COVID-19 and influenza
    Man Xing, Gaowei Hu, Xiang Wang, Yihan Wang, Furong He, Weiqian Dai, Xinyu Wang, Yixin Niu, Jiaojiao Liu, Hui Liu et al. · 2024 · npj Vaccines
  24. Pathogenesis of IgG4-related disease: a critical review
    Takashi Maehara, Masafumi Moriyama, Seiji Nakamura · 2018 · Odontology
  25. Immune memory in convalescent patients with asymptomatic or mild COVID-19
    Quanxin Long, Yanjun Jia, Xin Wang, Haijun Deng, Xiaoxia Cao, Jun Yuan, Liang Fang, Xu-Rong Cheng, Chao Luo, An-Ran He et al. · 2021 · Cell Discovery
  26. A Safe and Effective Mucosal RSV Vaccine Consisting of RSV Phosphoprotein and Flagellin Variant
    Bali Zhao, Jingyi Yang, Bing He, Xian Li, Hu Yan, Shuning Liu, Yi Yang, Dihan Zhou, Bowen Liu, Xuxu Fan et al. · 2021 · Cell Reports
  27. A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice
    Carly M. Bliss, Alec W. Freyn, Tom G. Caniels, Victor Hugo Leyva-Grado, Raffael Nachbagauer, Weina Sun, Gene S. Tan, Virginia Gillespie, Meagan McMahon, Florian Krammer et al. · 2022 · Molecular Therapy
  28. Intranasal vaccination with a replication-deficient influenza virus induces heterosubtypic neutralising mucosal IgA antibodies in humans
    Alexander Morokutti, Thomas Muster, Boris Ferko · 2014 · Vaccine
  29. Tissue Distribution of Memory T and B Cells in Rhesus Monkeys following Influenza A Infection
    Sathit Pichyangkul, Kosol Yongvanitchit, Amporn Limsalakpetch, Utaiwan Kum-Arb, Rawiwan Im‐Erbsin, Kobporn Boonnak, Thitithayanont Arunee, Anan Jongkaewwattana, Suwimon Wiboon-ut, Duangrat Mongkolsirichaikul et al. · 2015 · The Journal of Immunology
  30. M2SR, a novel live single replication influenza virus vaccine, provides effective heterosubtypic protection in mice
    Sally R. Sarawar, Yasuko Hatta, Shinji Watanabe, Peter B. Dias, Gabriele Neumann, Yoshihiro Kawaoka, Pamuk Bilsel · 2016 · Vaccine
  31. Short-Lived Antigen Recognition but Not Viral Infection at a Defined Checkpoint Programs Effector CD4 T Cells To Become Protective Memory
    Bianca Bautista, Priyadharshini Devarajan, Karl Kai McKinstry, Tara M. Strutt, Allen M. Vong, Michael C Jones, Yi Kuang, Daniel Mott, Susan L. Swain · 2016 · The Journal of Immunology
  32. The use of cell-mediated immunity for the evaluation of influenza vaccines: an upcoming necessity
    Elena Gianchecchi, Alessandro Torelli, Emanuele Montomoli · 2019 · Human Vaccines & Immunotherapeutics
  33. T Cell Immunity against Influenza: The Long Way from Animal Models Towards a Real-Life Universal Flu Vaccine
    Anna P. Schmidt, Dennis Lapuente · 2021 · Viruses
  34. Adenoviral Vectors as Vaccines for Emerging Avian Influenza Viruses
    Lucas J. Kerstetter, Stephen Buckley, Carly M. Bliss, Lynda Coughlan · 2021 · Frontiers in Immunology
  35. T-cell-mediated cross-strain protective immunity elicited by prime–boost vaccination with a live attenuated influenza vaccine
    Junwei Li, Maria T. Arévalo, Yanping Chen, Shan Chen, Mingtao Zeng · 2014 · International Journal of Infectious Diseases
  36. Induction of Human T-cell and Cytokine Responses Following Vaccination with a Novel Influenza Vaccine
    David A. G. Skibinski, Leigh Ann Jones, Yuan O. Zhu, Lin Wu Xue, Bijin Veonice Au, Bernett Teck Kwong Lee, Ahmad Nazri Mohamed Naim, Audrey W. Q. Lee, Nivashini Kaliaperumal, Jenny Guek Hong Low et al. · 2018 · Scientific Reports
  37. T and B Cell Immune Responses to Influenza Viruses in Pigs
    Barbara Holzer, Veronica Martini, Matthew D. Edmans, Elma Z. Tchilian · 2019 · Frontiers in Immunology
  38. Innate-like Gene Expression of Lung-Resident Memory CD8+ T Cells during Experimental Human Influenza: A Clinical Study
    Suzanna Paterson, Satwik Kar, Seng Kuong Anakin Ung, Zoe Gardener, Emma Bergstrom, Stephanie Ascough, Mohini Kalyan, Joanna Żyła, Jeroen Maertzdorf, Hans‐Joachim Mollenkopf et al. · 2021 · American Journal of Respiratory and Critical Care Medicine
  39. Review of Influenza Virus Vaccines: The Qualitative Nature of Immune Responses to Infection and Vaccination Is a Critical Consideration
    Lily Chan, Kasra Alizadeh, Kimia Alizadeh, Fatemeh Fazel, Julia E. Kakish, Negar Karimi, Jason P. Knapp, Yeganeh Mehrani, Jessica A. Minott, Solmaz Morovati et al. · 2021 · Vaccines
  40. Human influenza virus challenge identifies cellular correlates of protection for oral vaccination
    David R. McIlwain, Han M. Chen, Zainab Rahil, Neda Hajiakhoond Bidoki, Sizun Jiang, Zach B. Bjornson, Nikita S. Kolhatkar, Carlos Martínez, Brice L Gaudilliere, Julien Jacques Hedou et al. · 2021 · Cell Host & Microbe
  41. CD29 Enriches for Cytotoxic Human CD4+ T Cells
    Benoît P. Nicolet, Aurélie Guislain, Monika C. Wolkers · 2021 · The Journal of Immunology
  42. Targets and cross-reactivity of human T cell recognition of common cold coronaviruses
    Alison Tarke, Yun Zhang, Nils Methot, Tara M. Narowski, Elizabeth Jane Phillips, Simon Alexander Mallal, April Frazier, Gilberto Filaci, Daniela Weiskopf, Jennifer M. Dan et al. · 2023 · Cell Reports Medicine
  43. Differential evolution of peripheral cytokine levels in symptomatic and asymptomatic responses to experimental influenza virus challenge
    Micah T. McClain, Ricardo Henao, J Williams, B Nicholson, Timothy Veldman, L Hudson, Ephraim L. Tsalik, Rob Lambkin‐Williams, Anthony Gilbert, Alex Mann et al. · 2015 · Clinical & Experimental Immunology
  44. Norovirus-Specific Memory T Cell Responses in Adult Human Donors
    Maria Malm, Kirsi Tamminen, Timo Vesikari, Vesna Blazevic · 2016 · Frontiers in Microbiology
  45. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice
    Peter H. Goff, Tomoko Hayashi, Wenqian He, Shiyin Yao, Howard Brinkerhoff Cottam, Gene S. Tan, Brian Crain, Florian Krammer, Karen S. Messer, Minya Pu et al. · 2017 · Journal of Virology
  46. The Role of Pre-existing Cross-Reactive Central Memory CD4 T-Cells in Vaccination With Previously Unseen Influenza Strains
    Mikalai Nienen, Ulrik Stervbo, Felix Mölder, Sviatlana Kaliszczyk, Lèon Kuchenbecker, Ludmila Gayova, Brunhilde Schweiger, Karsten Jürchott, Jochen Hecht, Avidan Uriel Neumann et al. · 2019 · Frontiers in Immunology
  47. Clinical Effectiveness of Split-Virion Versus Subunit Trivalent Influenza Vaccines in Older Adults
    H. Keipp Talbot, Hui Nian, Yuwei Zhu, Qing Chen, John V. Williams, Marie R. Griffin · 2015 · Clinical Infectious Diseases
  48. Reduced Plasmodium Parasite Burden Associates with CD38+ CD4+ T Cells Displaying Cytolytic Potential and Impaired IFN-γ Production
    Julie G. Burel, Simon Hall Apte, Penny Groves, Kerenaftali Klein, James S. McCarthy, Denise L. Doolan · 2016 · PLoS Pathogens
  49. Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells
    Elena Muraro, Anna Merlo, Debora Martorelli, Michela Cangemi, Silvia Dalla Santa, Riccardo Dolcetti, Antonio Rosato · 2017 · Frontiers in Immunology
  50. Seasonal quadrivalent mRNA vaccine prevents and mitigates influenza infection
    Christina M. Kackos, Jennifer DeBeauchamp, Christopher J.H. Davitt, Jan Lonzarić, Robert E. Sealy, Julia L. Hurwitz, Marcelo M. Samsa, Richard J. Webby · 2023 · npj Vaccines
  51. Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles
    Suvi Lappalainen, Kirsi Tamminen, Timo Vesikari, Vesna Blazevic · 2013 · Human Vaccines & Immunotherapeutics
  52. Sortase A Induces Th17-Mediated and Antibody-Independent Immunity to Heterologous Serotypes of Group A Streptococci
    Xin Fan, Xiaoshuang Wang, Ning Li, Honglian Cui, Baidong Hou, Bin Gao, Paul Patrick Cleary, Beinan Wang · 2014 · PLoS ONE
  53. Prior infection with influenza virus but not vaccination leaves a long-term immunological imprint that intensifies the protective efficacy of antigenically drifted vaccine strains
    Jin Hyang Kim, Justine S. Liepkalns, Adrian J. Reber, Xiuhua Lu, Nedzad Music, Joshy Jacob, Suryaprakash R. Sambhara · 2015 · Vaccine
  54. Influenza and Memory T Cells: How to Awake the Force
    Jan Spitaels, Kenny Roose, Xavier Saelens · 2016 · Vaccines
  55. Evaluation of the immunogenicity and safety of different doses and formulations of a broad spectrum influenza vaccine (FLU-v) developed by SEEK: study protocol for a single-center, randomized, double-blind and placebo-controlled clinical phase IIb trial
    Eva van Doorn, Olga Pleguezuelos, Heng Liu, Ana Fernandez, Robin Bannister, Gregory A. Stoloff, Fredrik Oftung, Stephen Norley, Anke L. W. Huckriede, Henderik Willem Frijlink et al. · 2017 · BMC Infectious Diseases
  56. Cellular immune responses of older adults to four influenza vaccines: Results of a randomized, controlled comparison
    Arun Kumar, Janet E. McElhaney, Lisa D. Walrond, Terry Donald Cyr, Shahzma Merani, Tobias R. Kollmann, Scott A. Halperin, David W. Scheifele · 2017 · Human Vaccines & Immunotherapeutics
  57. The Hurdles From Bench to Bedside in the Realization and Implementation of a Universal Influenza Vaccine
    Sophie A. Valkenburg, Nancy Leung, Maireid B. Bull, Li-Meng Yan, Athena P. Y. Li, Leo L. M. Poon, Benjamin John Cowling · 2018 · Frontiers in Immunology
  58. Universal Influenza Vaccines: Progress in Achieving Broad Cross-Protection In Vivo
    Suzanne L. Epstein · 2018 · American Journal of Epidemiology
  59. SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial
    Αναστασία Παπαδοπούλου, George Karavalakis, Efthymia Papadopoulou, Aliki Xochelli, Zoi Bousiou, Anastasios Vogiatzoglou, Penelope Georgia Papayanni, Aphrodite Georgakopoulou, Maria Giannaki, Fani Stavridou et al. · 2023 · Nature Medicine
  60. Measuring Cellular Immunity to Influenza: Methods of Detection, Applications and Challenges
    Lynda Coughlan, Teresa Lambe · 2015 · Vaccines
  61. Flow Cytometric and Cytokine ELISpot Approaches To Characterize the Cell-Mediated Immune Response in Ferrets following Influenza Virus Infection
    Anthony T. DiPiazza, Katherine A. Richards, Frances Batarse, Laura Lockard, Hui Zeng, Adolfo García‐Sastre, Randy A. Albrecht, Andrea J. Sant · 2016 · Journal of Virology
  62. Augmenting Influenza-Specific T Cell Memory Generation with a Natural Killer T Cell-Dependent Glycolipid–Peptide Vaccine
    Regan J. Anderson, Jasmine Li, Łukasz Kedzierski, Benjamin J. Compton, Colin M. Hayman, Taryn L. Osmond, Ching-wen Tang, Kathryn J. Farrand, Hui‐Fern Koay, Catarina F. Almeida et al. · 2017 · ACS Chemical Biology
  63. Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines
    Wei Dong, Yoshita C. Bhide, Federica Sicca, Tjarko Meijerhof, Kate A. Guilfoyle, Othmar G. Engelhardt, Louis Boon, Cornelis A. M. de Haan, George Carnell, Nigel James Temperton et al. · 2018 · Frontiers in Immunology
  64. Multifunctional cytokine production reveals functional superiority of memory CD4 T cells
    Lotus M Westerhof, Kris McGuire, Lindsay MacLellan, Ashley Flynn, Joshua I. Gray, Matthew C. Thomas, Carl S. Goodyear, Megan K. L. MacLeod · 2019 · European Journal of Immunology
  65. Immunologic mechanisms of seasonal influenza vaccination administered by microneedle patch from a randomized phase I trial
    Nadine Rouphael, Lilin Lai, Sonia Tandon, Michele Paine McCullough, Yunchuan Kong, Sarah Kabbani, Muktha S. Natrajan, Yongxian Xu, Yerun Zhu, Dongli Wang et al. · 2021 · npj Vaccines
  66. Integrated single-cell analysis revealed immune dynamics during Ad5-nCoV immunization
    Qi-Qi Cao, Shi-Po Wu, Chuan-Le Xiao, Shu-Zhen Chen, Xiang-Yang Chi, Xiuliang Cui, Hao Tang, Wen-Ru Su, Ying-Feng Zheng, Jia-Yong Zhong et al. · 2021 · Cell Discovery
  67. The Nucleocapsid Protein of Rift Valley Fever Virus Is a Potent Human CD8+ T Cell Antigen and Elicits Memory Responses
    Weidong Xu, Douglas M. Watts, Margaret C. Costanzo, Xiaolei Tang, Leon A. Venegas, Jiao Feng, Alessandro Sette, John Sidney, Andrew Kelvin Sewell, Linda Wooldridge et al. · 2013 · PLoS ONE
  68. Predominance of heterosubtypic IFN ‐γ‐only‐secreting effector memory T cells in pandemic H 1 N 1 naive adults
    Saranya Sridhar, Shaima Begom, Alison Bermingham, Thedi T. Ziegler, Kim L. Roberts, William Barclay, Peter Openshaw, Ajit Lalvani · 2012 · European Journal of Immunology
  69. Systems Biology of Vaccination in the Elderly
    Sai Duraisingham, Nadine Rouphael, Mary Cavanagh, Helder Imoto Nakaya, Jörg J. Goronzy, Bali Pulendran · 2012 · Current topics in microbiology and immunology
  70. An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Infection
    Rob Lambkin‐Williams, Colin M Gelder, Richard Broughton, Corey P. Mallett, Anthony S. Gilbert, Alex Mann, David Y. He, JOHN S. OXFORD, David S. Burt · 2016 · PLoS ONE
  71. Vaccination with viral vectors expressing NP, M1 and chimeric hemagglutinin induces broad protection against influenza virus challenge in mice
    Guha Asthagiri Arunkumar, Meagan McMahon, Vincent Pavot, Mario Aramouni, Andriani Ioannou, Teresa Lambe, Sarah C. Gilbert, Florian Krammer · 2019 · Vaccine
  72. Direct interaction of whole-inactivated influenza A and pneumococcal vaccines enhances influenza-specific immunity
    Shannon C. David, Todd S. Norton, Timona S. Tyllis, Jasmine J. Wilson, Eve V. Singleton, Zoe Laan, Justin Bryan Davies, Timothy R. Hirst, Iain Comerford, Shaun R. McColl et al. · 2019 · Nature Microbiology
  73. Early Induction of Cross-Reactive CD8+ T-Cell Responses in Tonsils After Live-Attenuated Influenza Vaccination in Children
    Kristin Greve-Isdahl Mohn, Karl Albert Brokstad, Shahinul Islam, Fredrik Oftung, Camilla Tøndel, Hans Jørgen Aarstad, Rebecca Jane Cox · 2019 · The Journal of Infectious Diseases
  74. Progress on adenovirus-vectored universal influenza vaccines
    Kui Xiang, Ying Guan, Zhou Yan, Yan Shanshan, Lei Zhang, Hongjun Li, Sun Maosheng · 2015 · Human Vaccines & Immunotherapeutics
  75. Synthetic Long Peptide Influenza Vaccine Containing Conserved T and B Cell Epitopes Reduces Viral Load in Lungs of Mice and Ferrets
    Sietske K. Rosendahl Huber, Marcel G M Camps, Ronald H. J. Jacobi, Justin Mouthaan, Harry van Dijken, Josine van Beek, FERRY A. OSSENDORP, Jørgen de Jonge · 2015 · PLoS ONE
  76. PD-L1 Expression Induced by the 2009 Pandemic Influenza A(H1N1) Virus Impairs the Human T Cell Response
    Nuriban Valero-Pacheco, Lourdes Arriaga‐Pizano, Eduardo Antonio Ferat-Osorio, Luz María Mora-Velandia, Rodolfo Pastelin‐Palacios, Miguel Ángel Villasís-Keever, Celia Mercedes Alpuche-Aranda, Luvia Enid Sánchez‐Torres, Armando Isibasi, Laura C. Bonifaz et al. · 2013 · Clinical and Developmental Immunology
  77. Inactivated influenza virus vaccines: the future of TIV and QIV
    Michael Schotsaert, Adolfo García‐Sastre · 2017 · Current Opinion in Virology
  78. Lethal Influenza in Two Related Adults with Inherited GATA2 Deficiency
    Ithaisa Sologuren, María T. Martínez-Saavedra, Jordi Solé‐Violán, Edgar de Borges de Oliveira, Eva Betancor, Inmaculada Casas, Carmen Oleaga‐Quintas, Mónica Martínez‐Gallo, Shen‐Ying Zhang, J. Pestano et al. · 2018 · Journal of Clinical Immunology
  79. A PBMC-Based System to Assess Human T Cell Responses to Influenza Vaccine Candidates In Vitro
    Gabriela Tapia-Calle, Philip A. Born, Georgia Koutsoumpli, Martín Ignacio González‐Rodríguez, Wouter L.J. Hinrichs, Anke L. W. Huckriede · 2019 · Vaccines
  80. CD 4+ T ‐cell immunity after pandemic influenza vaccination cross‐reacts with seasonal antigens and functionally differs from active influenza infection
    Tina Schmidt, Jan Dirks, Martin Enders, Barbara Christine Gärtner, Heike Uhlmann‐Schiffler, Urban Sester, Martina Sester · 2012 · European Journal of Immunology
  81. Experimental H1N1pdm09 infection in pigs mimics human seasonal influenza infections
    Theresa Schwaiger, Julia Sehl‐Ewert, Claudia Karte, Alexander Schäfer, Jane Hühr, Thomas C. Mettenleiter, Charlotte Schröder, Bernd Köllner, Reiner Ulrich, Ulrike Blohm · 2019 · PLoS ONE
  82. Immunity to the Conserved Influenza Nucleoprotein Reduces Susceptibility to Secondary Bacterial Infections
    Laura Haynes, Frank M. Szaba, Sheri M. Eaton, Lawrence W. Kummer, Paula A. Lanthier, Ashlee H. Petell, Debra K. Duso, Deyan Luo, Jr‐Shiuan Lin, Julie S. Lefebvre et al. · 2012 · The Journal of Immunology
  83. Prospects for Broadly Protective Influenza Vaccines
    John Jay Treanor · 2015 · American Journal of Preventive Medicine
  84. Microbiota epitope similarity either dampens or enhances the immunogenicity of disease-associated antigenic epitopes
    Sebastian Carrasco Pro, Cecilia S. Lindestam Arlehamn, Sandeep Kumar Dhanda, Chelsea Carpenter, Mikaela Lindvall, Ali A. Faruqi, Clark A. Santee, Harald Renz, John Sidney, Bjoern Peters et al. · 2018 · PLoS ONE
  85. Protection by universal influenza vaccine is mediated by memory CD4 T cells
    Sophie A. Valkenburg, Olive T. W. Li, Athena Li, Maireid B. Bull, Thomas A. Waldmann, Liyanage P. Perera, Malik J. S. Peiris, Leo L. M. Poon · 2018 · Vaccine
  86. Long-term adaptation of the influenza A virus by escaping cytotoxic T-cell recognition
    Rutger G. Woolthuis, Christiaan Hendrik van Dorp, Can Keşmir, Rob J. de Boer, Michiel van Boven · 2016 · Scientific Reports
  87. Differential serum cytokine responses to inactivated and live attenuated seasonal influenza vaccines
    Amritha Ramakrishnan, Keri N. Althoff, Joseph A. Lopez, Christian L. Coles, Jay H. Bream · 2012 · Cytokine
  88. Influenza-derived peptides cross-react with allergens and provide asthma protection
    Chrysanthi L. Skevaki, Christoph Hudemann, Mikhail N Matrosovich, Christian Möbs, Sinu Paul, Andreas Wachtendorf, Bilal Alashkar Alhamwe, Daniel P. Potaczek, Stefanie Hagner, Diethard Gemsa et al. · 2017 · Journal of Allergy and Clinical Immunology
  89. Characterization of pandemic influenza immune memory signature after vaccination or infection
    Olivia Bonduelle, Fabrice Carrat, Charles Edouard Luyt, Catherine Leport, Anne Mosnier, Nora Benhabilès, Anne Krivine, Flore Rozenberg, Nora Yahia, Assia Samri et al. · 2014 · Journal of Clinical Investigation
  90. Memory CD4 T Cell-Mediated Immunity against Influenza A Virus: More than a Little Helpful
    Karl Kai McKinstry, Richard W Dutton, Susan L. Swain, Tara M. Strutt · 2013 · Archivum Immunologiae et Therapiae Experimentalis
  91. Influenza A Virus Challenge Models in Cynomolgus Macaques Using the Authentic Inhaled Aerosol and Intra-Nasal Routes of Infection
    Anthony C. Marriott, Mike J Dennis, Jennifer A. Kane, Karen E. Gooch, Graham J. Hatch, Sally A. Sharpe, Claudia Prevosto, Gail Helen Leeming, Elsa-Gayle Zekeng, Karl J. Staples et al. · 2016 · PLoS ONE
  92. The Integrated Pulmonary Immune Response to Pneumonia
    Katrina E. Traber, Joseph P. Mizgerd · 2025 · Annual Review of Immunology
  93. T-Cell Immunity to Influenza A Viruses
    Emma J. Grant, Li Chen, Sergio M. Quiñones‐Parra, Ken C. Pang, Katherine Kedzierska, Weisan Chen · 2013 · Critical Reviews in Immunology
  94. Characterisation of a wild-type influenza (A/H1N1) virus strain as an experimental challenge agent in humans
    Jeannette M. Watson, James N. Francis, Sofie Mesens, Gabriel A Faiman, Jill Makin, PETER A. PATRIARCA, John Jay Treanor, Bertrand Georges, Campbell Bunce · 2015 · Virology Journal
  95. Artificial antigen‐presenting cells expressing HLA class II molecules as an effective tool for amplifying human specific memory CD4+ T cells
    Anthony Garnier, Mohamad Hamieh, Aurélie Drouet, Jérôme Leprince, Denis Vivien, Thierry Frébourg, Brigitte Le Mauff, Jean‐Baptiste Latouche, Olivier Toutirais · 2016 · Immunology and Cell Biology
  96. Concurrent influenza vaccination reduces anti-FVIII antibody responses in murine hemophilia A
    Jesse D. Lai, Paul C. Moorehead, Kate Sponagle, Katharina Nora Steinitz, Birgit Maria Reipert, Christine A. Hough, David Lillicrap · 2016 · Blood
  97. Effects of pre-existing orthopoxvirus-specific immunity on the performance of Modified Vaccinia virus Ankara-based influenza vaccines
    Arwen F. Altenburg, Stella E. Vogelzang-van Trierum, Erwin de Bruin, Dennis de Meulder, Carolien E. van de Sandt, Fiona R.M. van der Klis, Ron A. M. Fouchier, Marion Koopmans, Guus F. Rimmelzwaan, Rory D. de Vries · 2018 · Scientific Reports
  98. The Role of Nucleoprotein in Immunity to Human Negative-Stranded RNA Viruses—Not Just Another Brick in the Viral Nucleocapsid
    Maja Šantak, Zrinka Matić · 2022 · Viruses
  99. Immunomodulatory nanosystems: An emerging strategy to combat viral infections
    Sajmina Khatun, Chandra Lekha Putta, Arshadul Hak, Aravind Kumar Rengan · 2023 · Biomaterials and Biosystems
  100. Boosted Influenza-Specific T Cell Responses after H5N1 Pandemic Live Attenuated Influenza Virus Vaccination
    YanChun Peng, Beibei Wang, Kawsar R. Talaat, Ruth A. Karron, Timothy J. Powell, Hui Zeng, Danning Dong, Catherine J. Luke, Andrew James McMichael, Kanta Subbarao et al. · 2015 · Frontiers in Immunology